{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"AGL","limit":50},"count":50,"signals":[{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":162,"context":"closure provisions. We may be unable to obtain, maintain and enforce our intellectual property rights, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. 8 [Table of Contents](#ia11dd14718704a7fa9f8c3f2719cacd7_7) | | | Human Capital | | Overview At agilon, our people are an indispensabl","filed_date":"2026-02-25","accession":"0001628280-26-011655","full_text":"https://origin.rootz.global/static/filing/0001628280-26-011655.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":60,"context":"ctive Constituent Documents in any respect to Parent or a Loan Party other than the Borrower or any Subsidiary Guarantor that is a Significant Subsidiary that would reasonably be expected to have a Material Adverse Effect, (B) violate any other Requirement of Law applicable to Parent or such Loan Party (including Regulations T, U and X of the Federal Reserve Board), or any order or decree of any Governmental Authori","filed_date":"2026-02-12","accession":"0001628280-26-007671","full_text":"https://origin.rootz.global/static/filing/0001628280-26-007671.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":100,"match_count":16,"context":"ntment of Ernst & Young LLP as the Companys independent registered public accounting firm for the year ending December31, 2025 | | | 3 | Advisory vote to approve the compensation paid to the Companys named executive officers | | | | | | Stockholders will also be asked to transact such other business as may properly come before the Annual Meeting or any reconvened meeting following any adjournment or postponement thereof","filed_date":"2025-04-17","accession":"0001140361-25-014418","full_text":"https://origin.rootz.global/static/filing/0001140361-25-014418.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":162,"context":"closure provisions. We may be unable to obtain, maintain and enforce our intellectual property rights, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. | | | Human Capital | | Overview At agilon, our people are an indispensable contributor to our success and are critical to our ability","filed_date":"2025-02-25","accession":"0001628280-25-007721","full_text":"https://origin.rootz.global/static/filing/0001628280-25-007721.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":100,"match_count":17,"context":"tment of Ernst & Young LLP as the Companys independent registered public accounting firm for the year ending December 31, 2024 | | | 3 | Advisory vote to approve the compensation paid to the Companys named executive officers | | | 4 | Any such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof | | The board recommends that you vote FOR the election of each of the n","filed_date":"2024-04-18","accession":"0001140361-24-020533","full_text":"https://origin.rootz.global/static/filing/0001140361-24-020533.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":152,"context":"closure provisions. We may be unable to obtain, maintain and enforce our intellectual property rights, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. | | | Human Capital | | Overview People join agilon because of our vision: To transform the future of healthcare in communities across","filed_date":"2024-02-27","accession":"0001628280-24-007242","full_text":"https://origin.rootz.global/static/filing/0001628280-24-007242.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":17,"context":"its subsidiaries, taken as a whole (collectively, the Business), free and clear of all liens, encumbrances, claims and title defects (collectively, Liens) that would reasonably be expected to have a material adverse effect on the financial position, stockholders equity or results of operations of the Company and its subsidiaries, taken as a whole (a Material Adverse Effect), other than Liens granted or to be granted to","filed_date":"2023-05-18","accession":"0001193125-23-148146","full_text":"https://origin.rootz.global/static/filing/0001193125-23-148146.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":100,"match_count":19,"context":"nt of Ernst & Young LLP as the Companys independent registered public accounting firm for fiscal year 2023; | | | | 3. | Proposal 3: Advisory vote to approve the compensation paid to the Companys named executive officers; and | | | | 4. | Any such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. | | The board recommends that you vote **FOR** the electio","filed_date":"2023-04-14","accession":"0001140361-23-018402","full_text":"https://origin.rootz.global/static/filing/0001140361-23-018402.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":76,"context":"closure provisions. We may be unable to obtain, maintain and enforce our intellectual property rights, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. Human Capital Overview People join agilon because of our vision: To transform the future of healthcare in communities across the count","filed_date":"2023-03-01","accession":"0000950170-23-005541","full_text":"https://origin.rootz.global/static/filing/0000950170-23-005541.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":100,"match_count":14,"context":"ptions The stock options granted in 2021 to Messrs. Bensley and Venkatachaliah under the Prior Stock Incentive Plan consist of the following: (a) the Base Options which vest in four equal annual installments; and (b) the Upside Options which were subject to a performance condition that was later satisfied in 2021 (i.e., that the CD&R Investor realized a return of at least three times its initial inve","filed_date":"2022-04-11","accession":"0001140361-22-013984","full_text":"https://origin.rootz.global/static/filing/0001140361-22-013984.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":100,"match_count":23,"context":"ointment of Ernst & Young LLP as the Companys independent registered public accounting firm for fiscal year 2022; | | | 3. | Proposal 3: Advisory vote to approve the compensation paid to the Companys named executive officers; | | | 4. | Proposal 4: Advisory vote on the frequency of future advisory votes to approve the compensation paid to the Companys named executive officers; and | | | 5. | Any such other business as m","filed_date":"2022-04-11","accession":"0001140361-22-013984","full_text":"https://origin.rootz.global/static/filing/0001140361-22-013984.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":100,"match_count":13,"context":"the AKS upon which we regularly rely allows for payments to providers for “healthcare services and items,” but does not allow incentive payments for marketing or to encourage member enrollment. We therefore carefully analyze all payment structures to ensure that they constitute “services and items” that fall within this safe harbor or are otherwise in compliance with the A","filed_date":"2022-03-03","accession":"0000950170-22-002826","full_text":"https://origin.rootz.global/static/filing/0000950170-22-002826.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":72,"context":"closure provisions. We may be unable to obtain, maintain and enforce our intellectual property rights, and assertions by third parties that we violate their intellectual property rights could have a material adverse effect on our business, financial condition and results of operations. Human Capital Overview People join agilon because of our vision: To transform the future of healthcare in communities across the count","filed_date":"2022-03-03","accession":"0000950170-22-002826","full_text":"https://origin.rootz.global/static/filing/0000950170-22-002826.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":100,"match_count":41,"context":"| | | The Medicare population is projected to grow from approximately 62 million in 2020 to more than 70 million individuals in 2025 with a total spend of approximately $1.25 trillion, and MA enrollment is projected to comprise 47% of total Medicare enrollment (which we refer to as the MA penetration rate); and | | | | | | PCPs are positionedbut not currently empowered or incentivizedto act a","filed_date":"2021-09-07","accession":"0001193125-21-266585","full_text":"https://origin.rootz.global/static/filing/0001193125-21-266585.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":86,"context":"s equity and working capital. **Any failure by us to identify and develop successful new geographies, physician partners and payors and to successfully execute upon our growth initiatives may have a material adverse effect on our business, financial condition, cash flows and results of operations.** Our business depends on our ability to identify and develop successful geographies and relationships with physician partn","filed_date":"2021-09-07","accession":"0001193125-21-266585","full_text":"https://origin.rootz.global/static/filing/0001193125-21-266585.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":100,"match_count":28,"context":"million. In October 2020, we disposed of our Fresno, California operations for a gross sales price of $26.0 million and recognized a gain on sale of approximately $19.1 million. In December 2020, we signed a definitive agreement to sell our remaining California operations for a gross sales price of $1.0 million. The sale closed in February 2021. For the Southern California and Fresno divestiture transactions, we will continu","filed_date":"2021-09-07","accession":"0001193125-21-266585","full_text":"https://origin.rootz.global/static/filing/0001193125-21-266585.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":100,"match_count":41,"context":"| | | | The Medicare population is projected to grow from approximately 62million in 2020 to more than 70million individuals in 2025 with a total spend of approximately $1.25 trillion, and MA enrollment is projected to comprise 47% of total Medicare enrollment (which we refer to as the MA penetration rate); and | | | | | | PCPs are positionedbut not currently empowered or incentivizedto act a","filed_date":"2021-08-30","accession":"0001193125-21-260573","full_text":"https://origin.rootz.global/static/filing/0001193125-21-260573.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":100,"match_count":86,"context":"ers equity and working capital. Any failure by us to identify and develop successful new geographies, physician partners and payors and to successfully execute upon our growth initiatives may have a material adverse effect on our business, financial condition, cash flows and results of operations. Our business depends on our ability to identify and develop successful geographies and relationships with physician partne","filed_date":"2021-08-30","accession":"0001193125-21-260573","full_text":"https://origin.rootz.global/static/filing/0001193125-21-260573.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":100,"match_count":28,"context":"1.3million. In October 2020, we disposed of our Fresno, California operations for a gross sales price of $26.0million and recognized a gain on sale of approximately $19.1million. In December 2020, we signed a definitive agreement to sell our remaining California operations for a gross sales price of $1.0million. The sale closed in February 2021. For the Southern California and Fresno divestiture transactions, we will continue","filed_date":"2021-08-30","accession":"0001193125-21-260573","full_text":"https://origin.rootz.global/static/filing/0001193125-21-260573.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":98,"match_count":11,"context":"’s strategic partnerships to deliver healthcare services: • The Company operates an independent practice association (“IPA”) in Hawaii. • During 2017, the Company entered into a strategic partnership to expand its operations beginning January 1, 2018 into Columbus, Ohio. • During 2018, the Company entered into strategic partnerships to further expand its operations beginning January 1, 20","filed_date":"2022-03-03","accession":"0000950170-22-002826","full_text":"https://origin.rootz.global/static/filing/0000950170-22-002826.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":96,"match_count":12,"context":"fe harbor under the AKS upon which we regularly rely allows for payments to providers for healthcare services and items, but does not allow incentive payments for marketing or to encourage member enrollment. We therefore carefully analyze all payment structures to ensure that they constitute services and items that fall within this safe harbor or are otherwise in compliance with the AKS. We similarly","filed_date":"2026-02-25","accession":"0001628280-26-011655","full_text":"https://origin.rootz.global/static/filing/0001628280-26-011655.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":96,"match_count":12,"context":"NANCE | | | | | | | | The following matrix highlights the specific skills and qualifications the Nominating and Governance Committee currently believes are most important to the boards effective fulfillment of its roles. The absence of a designation does not mean a director does not possess that skill or qualification. Each director nominee offers unique viewpoints and experiences to meet the evolvin","filed_date":"2025-04-17","accession":"0001140361-25-014418","full_text":"https://origin.rootz.global/static/filing/0001140361-25-014418.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":96,"match_count":12,"context":"fe harbor under the AKS upon which we regularly rely allows for payments to providers for healthcare services and items, but does not allow incentive payments for marketing or to encourage member enrollment. We therefore carefully analyze all payment structures to ensure that they constitute services and items that fall within this safe harbor or are otherwise in compliance with the AKS. We similarly","filed_date":"2025-02-25","accession":"0001628280-25-007721","full_text":"https://origin.rootz.global/static/filing/0001628280-25-007721.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":88,"match_count":11,"context":"fe harbor under the AKS upon which we regularly rely allows for payments to providers for healthcare services and items, but does not allow incentive payments for marketing or to encourage member enrollment. We therefore carefully analyze all payment structures to ensure that they 11 [Table of Contents](#i28e5c047a53a4af79e729f74fc978df9_7) constitute services and items that fall within this safe ha","filed_date":"2024-02-27","accession":"0001628280-24-007242","full_text":"https://origin.rootz.global/static/filing/0001628280-24-007242.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":88,"match_count":11,"context":"the AKS upon which we regularly rely allows for payments to providers for “healthcare services and items,” but does not allow incentive payments for marketing or to encourage member enrollment. We therefore carefully analyze all payment structures to ensure that they constitute “services and items” that fall within this safe harbor or are otherwise in compliance with the A","filed_date":"2023-03-01","accession":"0000950170-23-005541","full_text":"https://origin.rootz.global/static/filing/0000950170-23-005541.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":87,"match_count":9,"context":"he state of Delaware in April 2017. The following provides information regarding the Company’s recent strategic partnerships to deliver healthcare services: • During 2020, the Company entered into a strategic partnership to further expand its operations beginning April 1, 2020 into Wilmington, North Carolina. Additionally, during 2020, the Company entered into strategic partnerships to further expand its operations b","filed_date":"2023-03-01","accession":"0000950170-23-005541","full_text":"https://origin.rootz.global/static/filing/0000950170-23-005541.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":84,"match_count":8,"context":"million for the years ended and December31, 2022 and 2021, respectively. Cash used in investing activities in 2023 was due primarily for the acquisition of our My Personal Health Record Express, Inc. acquisition for $44.4 million in 2023. The increase in net cash used in investing activities in 2022 compared to 2021 was due primarily to investments in marketable securities of $458.3 million during 2022. Net Cash P","filed_date":"2024-02-27","accession":"0001628280-24-007242","full_text":"https://origin.rootz.global/static/filing/0001628280-24-007242.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":80,"match_count":10,"context":"uded from the 2023 Adjusted EBITDA three-year performance period calculation. | ** | The market platform membership goals established by our Compensation and Human Capital Committee consisted of enrollment of individuals enrolled in a MA plan attributed to the primary care physicians (PCPs) on our platform. | | | | agilon health 2024 Proxy Statement| | 34 | | [TABLE OF CONTENTS](#TOC) | | | | EXECUT","filed_date":"2024-04-18","accession":"0001140361-24-020533","full_text":"https://origin.rootz.global/static/filing/0001140361-24-020533.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":72,"match_count":9,"context":"Compensation Risk Assessment The Compensation and Human Capital Committee assessed our compensation policies and practices to evaluate whether they create risks that are reasonably likely to have a material adverse effect on the Company. Based on its assessment, the Compensation and Human Capital Committee concluded that the Companys compensation policies and practices do not create incentives to take risks that are r","filed_date":"2024-04-18","accession":"0001140361-24-020533","full_text":"https://origin.rootz.global/static/filing/0001140361-24-020533.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":72,"match_count":9,"context":"blished at the time of grant, stock options create incentives for our executives to achieve share price appreciation that will benefit shareholders. These stock options vest in four equal annual installments. The exercise price of each outstanding stock option is set forth in the Exercise Price of Option Awards column of the Grants of Plan-Based Awards for Fiscal Year 2022 table. All stock options ex","filed_date":"2023-04-14","accession":"0001140361-23-018402","full_text":"https://origin.rootz.global/static/filing/0001140361-23-018402.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"strategic_event","strength":71,"match_count":7,"context":"incorporated in the state of Delaware in April 2017. The following provides information regarding the Companys recent strategic partnerships to deliver healthcare services: During 2020, the Company entered into a strategic partnership to further expand its operations beginning April 1, 2020 into Wilmington, North Carolina. Additionally, during 2020, the Company entered into strategic partnerships to further expand its operations b","filed_date":"2023-08-08","accession":"0001628280-23-028276","full_text":"https://origin.rootz.global/static/filing/0001628280-23-028276.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"platform_shift","strength":59,"match_count":3,"context":"the Fiscal Quarter ending March 31, 2021 and through and including the Fiscal Quarter ending March 31, 2022 any expenses related to actual or potential expansions (whether or not consummated) into new markets or resulting from any Person entering into new contracts or the actual or potential entry (whether or not consummated) into new ventures and any operating losses associated with any such expansion","filed_date":"2026-02-12","accession":"0001628280-26-007671","full_text":"https://origin.rootz.global/static/filing/0001628280-26-007671.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"restructuring","strength":56,"match_count":7,"context":"solidation, whether or not completed), any severance, relocation, consolidation, closing, integration, facilities opening, business optimization andor similar initiatives or programs, transition or restructuring costs, charges or expenses (whether or not classified as restructuring costs, charges or expenses on the consolidated financial statements of the Borrower), any signing, stretch, retention or completion","filed_date":"2026-02-12","accession":"0001628280-26-007671","full_text":"https://origin.rootz.global/static/filing/0001628280-26-007671.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":55,"match_count":5,"context":"Company is economically dependent on maintaining a base of primary care and specialty care physicians as well as capitation contracts with payors. The loss of certain of those contracts could have a material adverse effect on the Company’s financial position, results of operations, or cash flows. The Company contracts with various payors whereby the Company is entitled to monthly PMPM fees to provide a defined","filed_date":"2022-05-05","accession":"0000950170-22-007884","full_text":"https://origin.rootz.global/static/filing/0000950170-22-007884.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":55,"match_count":5,"context":"Company is economically dependent on maintaining a base of primary care and specialty care physicians as well as capitation contracts with payors. The loss of certain of those contracts could have a material adverse effect on the Company’s financial position, results of operations, or cash flows. The Company contracts with various payors whereby the Company is entitled to monthly PMPM fees to provide a defined","filed_date":"2021-10-28","accession":"0000950170-21-002473","full_text":"https://origin.rootz.global/static/filing/0000950170-21-002473.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":55,"match_count":5,"context":"Company is economically dependent on maintaining a base of primary care and specialty care physicians as well as capitation contracts with payors. The loss of certain of those contracts could have a material adverse effect on the Company’s financial position, results of operations, or cash flows. The Company contracts with various payors whereby the Company is entitled to monthly PMPM fees to provide a defined","filed_date":"2021-08-04","accession":"0000950170-21-000796","full_text":"https://origin.rootz.global/static/filing/0000950170-21-000796.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":55,"match_count":5,"context":"Company is economically dependent on maintaining a base of primary care and specialty care physicians as well as capitation contracts with payors. The loss of certain of those contracts could have a material adverse effect on the Companys financial position, results of operations, or cash flows. The Company contracts with various payors whereby the Company is entitled to monthly PMPM fees to provide a defined range of","filed_date":"2021-05-26","accession":"0001564590-21-030059","full_text":"https://origin.rootz.global/static/filing/0001564590-21-030059.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":55,"match_count":5,"context":"he ordinary course of the Company's business. Except as described below, the Company is not aware of any other legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company's business, prospects, financial condition, results of operations or cash flows. The Companys policy is to expense legal costs as they are incurred. 17 [Table of Contents](#i223d296909","filed_date":"2026-08-05","accession":"0001628280-26-053355","full_text":"https://origin.rootz.global/static/filing/0001628280-26-053355.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":53,"match_count":6,"context":"Compensation Risk Assessment The Compensation and Human Capital Committee assessed our compensation policies and practices to evaluate whether they create risks that are reasonably likely to have a material adverse effect on the Company. Based on its assessment, the Compensation and Human Capital Committee concluded that the Companys compensation policies and practices do not create incentives to take risks that are r","filed_date":"2025-04-17","accession":"0001140361-25-014418","full_text":"https://origin.rootz.global/static/filing/0001140361-25-014418.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_concentration","strength":53,"match_count":1,"context":"ctus. As a result, our key payors may have increased bargaining power, and we may be required to accept less favorable contractual terms with them. Because we rely on a limited number of payors for a significant portion of our revenue, we depend on their creditworthiness. Our payors are subject to a number of risks including reductions in payment rates from governmental programs, higher than expected healthcare costs and lack of p","filed_date":"2021-09-07","accession":"0001193125-21-266585","full_text":"https://origin.rootz.global/static/filing/0001193125-21-266585.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_concentration","strength":53,"match_count":1,"context":"ctus. As a result, our key payors may have increased bargaining power, and we may be required to accept less favorable contractual terms with them. Because we rely on a limited number of payors for a significant portion of our revenue, we depend on their creditworthiness. Our payors are subject to a number of risks including reductions in payment rates from governmental programs, higher than expected healthcare costs and lack of p","filed_date":"2021-08-30","accession":"0001193125-21-260573","full_text":"https://origin.rootz.global/static/filing/0001193125-21-260573.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":47,"match_count":4,"context":"ry course of the Company's business. Except as described in this Note 9, the Company is not aware of any other legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company's business, prospects, financial condition, results of operations or cash flows. The Companys policy is to expense legal costs as they are incurred. In February and March 2024, three c","filed_date":"2025-11-04","accession":"0001628280-25-048839","full_text":"https://origin.rootz.global/static/filing/0001628280-25-048839.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":47,"match_count":4,"context":"ry course of the Company's business. Except as described in this Note 9, the Company is not aware of any other legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company's business, prospects, financial condition, results of operations or cash flows. The Companys policy is to expense legal costs as they are incurred. In February and March 2024, three c","filed_date":"2025-08-04","accession":"0001628280-25-037430","full_text":"https://origin.rootz.global/static/filing/0001628280-25-037430.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":42,"match_count":4,"context":"Company is economically dependent on maintaining a base of primary care and specialty care physicians as well as capitation contracts with payors. The loss of certain of those contracts could have a material adverse effect on the Companys financial position, results of operations, or cash flows. The Company contracts with various payors whereby the Company is entitled to monthly PMPM fees to provide a defined range of","filed_date":"2023-08-08","accession":"0001628280-23-028276","full_text":"https://origin.rootz.global/static/filing/0001628280-23-028276.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":42,"match_count":4,"context":"a significant relationship to, legal proceedings, lawsuits, and other claims. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company’s financial condition, results of operations or cash flows. The Company’s policy is to expense legal costs as they are incurred. COVID-19 The Company continues to monito","filed_date":"2022-11-03","accession":"0000950170-22-021905","full_text":"https://origin.rootz.global/static/filing/0000950170-22-021905.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":42,"match_count":4,"context":"to, legal proceedings, lawsuits, and other claims. Except as described below, the Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company’s financial condition, results of operations or cash flows. The Company’s policy is to expense legal costs as they are incurred. COVID-19 The Company continues to monito","filed_date":"2022-08-04","accession":"0000950170-22-014787","full_text":"https://origin.rootz.global/static/filing/0000950170-22-014787.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"ai_adoption","strength":40,"match_count":5,"context":"h such Disposition or Property Loss Event, and (iv) in the case of an Disposition or Property Loss Event of or involving an asset subject to a Lien securing any Indebtedness, payments made and installment payments required to be made to repay such Indebtedness, including payments by Borrower or any of its Restricted Subsidiaries in respect of principal, interest and prepayment premiums and penal","filed_date":"2026-02-12","accession":"0001628280-26-007671","full_text":"https://origin.rootz.global/static/filing/0001628280-26-007671.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"risk_factor","strength":40,"match_count":5,"context":"Compensation Risk Assessment** The Compensation and Human Capital Committee assessed our compensation policies and practices to evaluate whether they create risks that are reasonably likely to have a material adverse effect on the Company. Based on its assessment, the Compensation and Human Capital Committee concluded that the Companys compensation policies and practices do not create incentives to take risks that are r","filed_date":"2023-04-14","accession":"0001140361-23-018402","full_text":"https://origin.rootz.global/static/filing/0001140361-23-018402.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"platform_shift","strength":40,"match_count":5,"context":"orecard was 100%. The chronic care reassessment rate goals established by our Compensation and Human Capital Committee consisted of a threshold reassessment rate of 80% in existing markets and 75% in new markets (which 21 [TABLE OF CONTENTS](#TOC) achievement below this threshold would result in no bonus being earned with respect to this metric, but, if achieved, would result in a payout of 50% of target i","filed_date":"2022-04-11","accession":"0001140361-22-013984","full_text":"https://origin.rootz.global/static/filing/0001140361-22-013984.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"AGL","company":"agilon health, inc.","exchange":"NYSE","sector":"Services-Misc Health & Allied Services, NEC","signal_type":"growth_inflection","strength":40,"match_count":5,"context":"m has enabled us to grow revenue 53% year-over-year for the year ended December 31, 2020, while operating costs to support live geographies and enterprise functions grew 12% over the same period. Our revenue grew 67% year-over-year for the year ended December 31, 2019, while operating costs to support live geographies and enterprise functions grew 42% over the same period. Our net loss for the year ended December","filed_date":"2021-09-07","accession":"0001193125-21-266585","full_text":"https://origin.rootz.global/static/filing/0001193125-21-266585.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"e3372342b1dff28a27ae482c4c7c0e3408cebd427dc1bdac7c9fb82daa6da112","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"469bfde3e8287bd911a2375cc8391f34342cfe9c90c320b35d8042793858fbac","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256() || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":489,"hourly_limit":500,"remaining":11,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}